ClinConnect ClinConnect Logo
Search / Trial NCT05743478

Forging Hopeful Futures to Reduce Youth Violence

Launched by UNIVERSITY OF PITTSBURGH · Feb 14, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The trial titled "Forging Hopeful Futures to Reduce Youth Violence" is studying a special program designed to help young people, aged 13 to 19, prevent violence and improve their coping and communication skills. This program focuses on important social issues like race, gender, and economic fairness. By participating, teens will have the opportunity to learn how to handle conflicts and express themselves better, all while being part of a supportive community.

To join the study, participants must be between 13 and 19 years old, speak English, and either live, go to school, or use facilities in certain neighborhoods involved in the trial. Participants will be asked to provide their contact information for follow-up. The program is currently looking for volunteers, and it's a chance for young people to gain valuable skills while contributing to important research on reducing violence in their communities.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Participants must be ages 13-19 (inclusive)
  • 2. Participants must speak English
  • 3. Participants must live in the participating neighborhoods, attend schools in the participating neighborhoods, or use participating facilities
  • 4. Participants must be able to provide follow up contact information
  • Exclusion Criteria:
  • 1. Not ages 13 -19 (inclusive)
  • 2. Do not speak English
  • 3. Do not live in the participating neighborhoods, attend schools in the participating neighborhoods, or use participating facilities
  • 4. Unable to provide follow up contact information

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Pittsburgh, Pennsylvania, United States

Pittsburgh, Pennsylvania, United States

Washington, District Of Columbia, United States

Patients applied

0 patients applied

Trial Officials

Alison Culyba, MD PhD MPH

Principal Investigator

University of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials